https://www.cnn.com/2023/07/26/opinions/leqembi-alzheimers-drug-fda-approved-honig/index.html
The development and approval of Leqembi, the first FDA-approved medication proven to slow the progression of Alzheimer’s disease, is a milestone. But there is a need to develop drugs with greater effectiveness, and that can be given to more people with AD at …
Create an account or login to join the discussion